Notes to the consolidated financial statements
98
17 Receivables (continued)
-
18 Other current financial assets
Ahold at a glance
Business review
Governance
Financials
Ahold
Annual Report 2014
At December 29, 2013, the aging analysis of receivables was as follows:
Past due
millior
Total
Not past
due
0-3
months
3-6
months
6-12
months
12
months
Trade receivables
358
282
49
11
4
12
Vendor allowance receivables
191
152
35
3
1
Other receivables
135
84
28
13
5
5
684
518
112
27
10
17
Provision for impairment
(19)
(2)
(1)
(2)
(14)
Total receivables
665
518
110
26
The concentration of credit risk with respect to receivables is limited, as the Company's customer base and vendor base are large and unrelated. The Company does not hold any significant collateral on its receivables.
Management believes there is no further credit risk provision required in excess of the normal individual and collective impairment, based on the aging analysis performed as of December 28, 2014. For more information
about credit risk, see Note 30.
The changes in the provision for impairment were as follows:
million
2014
2013
Beginning of the year
(19)
(17)
Released (charged) to income
(8)
(9)
Used
7
6
Exchange rate differences
1
End of the year
(20)
(19)
million
December 28,
2014
December 29,
2013
Short-term deposits and similar instruments
262
1,467
Reinsurance assets - current portion (see Note 15)
60
47
Other
1
6
Total other current financial assets
323
1,520
As per December 28, 2014, short-term deposits and similar instruments included short-term investments with a maturity at acquisition of between three and twelve months.
Of the short-term deposits and similar instruments as of December 28, 2014, €16 million was restricted (December 29, 2013: €15 million). This primarily consisted of investments held for insurance purposes for U.S. workers'
compensation and general liability programs.
Other mainly consists of the current portion of the derivative financial instruments. For more information on financial instruments and fair values, see Note 30.